FRX — Fennec Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$348.11m
- CA$371.12m
- $21.25m
- 21
- 22
- 56
- 24
Annual cashflow statement for Fennec Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.8 | -18.1 | -17.3 | -23.7 | -16 |
| Non-Cash Items | 3.15 | 3.28 | 4.06 | 4.55 | 5.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.569 | -0.763 | -0.932 | 1.1 | -6.78 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -9.06 | -15.6 | -14.2 | -18.1 | -17.1 |
| Financing Cash Flow Items | 0 | — | -0.055 | -0.131 | -0.075 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.071 | 32.3 | 4.98 | 20.7 | 6.64 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.13 | 16.7 | -9.24 | 2.67 | -10.5 |